申请人:BASF Aktiengesellschaft
公开号:US04251539A1
公开(公告)日:1981-02-17
Alkylamino-propanol derivatives of 3-alkyl-5-(2-hydroxystyryl)-isoxazole, of the general formula ##STR1## where R is hydrogen, alkyl of 1 to 8 carbon atoms, which is unsubstituted or substituted by hydroxyl, alkoxy of 1 to 3 carbon atoms or cycloalkyl with 3 to 8 carbon atoms in the ring, alkenyl or alkynyl of 2 to 8 carbon atoms, or cycloalkyl with 3 to 8 carbon atoms in the ring, the cycloalkyl rings being unsubstituted or mono- or di-substituted by alkyl of 1 to 3 carbon atoms, and R' is alkyl of 1 to 4 carbon atoms, and their addition salts with physiologically acceptable acids, their preparation, and pharmaceutical formulations which contain these compounds and which can be used as valuable drugs in the treatment of hypertonia, coronary diseases of the heart and cardiac arrhythmias.
3-烷基-5-(2-羟基苯乙烯基)-异噁唑的烷基氨基丙醇衍生物,其一般式为##STR1##其中R为氢,1至8个碳原子的烷基,未取代或取代为羟基,1至3个碳原子的烷氧基或3至8个碳原子的环状烷基,2至8个碳原子的烯基或炔基,或3至8个碳原子的环状烷基,环状烷基环未取代或被1至3个碳原子的烷基单取代或双取代,R'为1至4个碳原子的烷基,以及它们与生理上可接受的酸的加合盐,它们的制备和含有这些化合物的制药配方,可用作治疗高血压、心脏冠状动脉疾病和心脏心律失常的有价值的药物。